Located at Hyderabad, Telangana
Granules India announced that Company's Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content